Skip to search form
Skip to main content
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Pralatrexate Injection [Folotyn]
National Institutes of Health
2 ML Pralatrexate 20 MG/ML Injection [Folotyn]
Semantic Scholar uses AI to extract papers important to this topic.
Identification of An Active, Well-Tolerated Dose of Pralatrexate In Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL): Final Results of a Multicenter Dose-Finding Study.
Steven M Horwitz
Youn Hui Kim
Abstract 2800 Background: Pralatrexate (FOLOTYN®) is an antifolate designed for preferential tumor uptake and accumulation…
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE